NANOCAFLANONE
Live / Allowed — First extension granted (statement of use) (as of 20 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99214024
- Mark type
- Word mark
- Filed
- 02 Jun 2025
- Published for opposition
- 25 Nov 2025
- Attorney of record
- Benjamen E. Kern
Goods and services
- Class 005 — Pharmaceuticals: Diagnostic agents, preparations and substances for medical purposes; diagnostic agents for medical use, namely, diagnostic agents for in vivo use; pharmaceutical diagnostic preparations for medical use; pharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases; Pharmaceutical compositions for detection, diagnosis, and treatment of central nervous system disorders, cancers, and inflammatory diseases
Owner
- Flavocure Biotech Inc., Baltimore, MD, US
- Flavocure Biotech Inc., Baltimore, MD, US
Prosecution history
- 21 Jul 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jul 2026 — SOU EXTENSION 1 GRANTED
- 20 Jul 2026 — SOU EXTENSION 1 FILED
- 20 Jul 2026 — SOU TEAS EXTENSION RECEIVED
- 20 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Nov 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Nov 2025 — PUBLISHED FOR OPPOSITION
- 19 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Oct 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Oct 2025 — EXAMINER'S AMENDMENT ENTERED
- 24 Oct 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 24 Oct 2025 — EXAMINERS AMENDMENT E-MAILED
- 24 Oct 2025 — EXAMINERS AMENDMENT -WRITTEN
- 21 Oct 2025 — ASSIGNED TO EXAMINER
- 02 Jun 2025 — APPLICATION FILING RECEIPT MAILED